Core Alternative Capital
- SEC CIK
- 0001776878
- Latest filing
- Aug 14, 2026
ABBV holding history
AbbVie Inc. in every 13F filed by Core Alternative Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,976
- Value
- $748.9K
- % of portfolio
- 0.2%
- Quarters held
- 20
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,976 | $748.9K | 0.2% | +464+18.5% | Added | Holders |
| Q1 2026 | 2,512 | $546.3K | 0.2% | +357+16.6% | Added | Holders |
| Q4 2025 | 2,155 | $492.4K | 0.1% | +1,872+661.5% | Added | Holders |
| Q3 2025 | 283 | $65.5K | <0.1% | +3+1.1% | Added | Holders |
| Q2 2025 | 280 | $52.0K | <0.1% | −2,772−90.8% | Reduced | Holders |
| Q1 2025 | 3,052 | $639.5K | 0.2% | −82−2.6% | Reduced | Holders |
| Q4 2024 | 3,134 | $556.9K | 0.1% | −803−20.4% | Reduced | Holders |
| Q3 2024 | 3,937 | $777.5K | 0.2% | +150+4.0% | Added | Holders |
| Q2 2024 | 3,787 | $649.5K | 0.1% | −8−0.2% | Reduced | Holders |
| Q1 2024 | 3,795 | $691.1K | 0.1% | −772−16.9% | Reduced | Holders |
| Q4 2023 | 4,567 | $707.7K | 0.1% | −1,018−18.2% | Reduced | Holders |
| Q3 2023 | 5,585 | $832.5K | 0.1% | +2,988+115.1% | Added | Holders |
| Q2 2023 | 2,597 | $349.9K | 0.1% | +176+7.3% | Added | Holders |
| Q1 2023 | 2,421 | $385.9K | 0.1% | +90+3.9% | Added | Holders |
| Q4 2022 | 2,331 | $376.7K | <0.1% | −401−14.7% | Reduced | Holders |
| Q3 2022 | 2,732 | $367.0K | 0.1% | −156−5.4% | Reduced | Holders |
| Q2 2022 | 2,888 | $442.0K | 0.1% | +1,080+59.7% | Added | Holders |
| Q1 2022 | 1,808 | $293.0K | 0.1% | +1,490+468.6% | Added | Holders |
| Q4 2021 | 318 | $43.0K | <0.1% | +60+23.3% | Added | Holders |
| Q3 2021 | 258 | $28.0K | <0.1% | +258 | New | Holders |